SCHEMBL8086972

SCHEMBL8086972

CCOC(=O)CC1=C[N]c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 3/20 0.41
HSP90AA1 P07900 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
HIF1A Q16665 1/20 0.41
PKM P14618 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.40
RECQL P46063 1/20 0.40
CYP1A2 P05177 1/20 0.39
TSHR P16473 2/20 0.39
USP2 O75604 1/20 0.39
MAPK1 P28482 1/20 0.39
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8087155 0.80 AKR1B1 (0.42) ALDH1A1LMNAHTTTSHRCA12
SCHEMBL3663637 0.73 HSD17B10 (0.43) HSD17B10SMN1; SMN2ALDH1A1LMNAHSP90AA1
SCHEMBL3703857 0.70 SMN1; SMN2 (0.42) HSD17B10SMN1; SMN2ALDH1A1PKMCYP1A2
SCHEMBL31686158 0.70 SMN1; SMN2 (0.42) HSD17B10SMN1; SMN2ALDH1A1PKMCYP1A2
SCHEMBL68340 0.69 PKM (0.60) HSD17B10SMN1; SMN2ALDH1A1LMNAPKM
SCHEMBL12602244 0.68 ALDH1A1 (0.43) HSD17B10ALDH1A1MAPTHTTPKM
SCHEMBL7403188 0.68 KDM4E (0.47) SMN1; SMN2ALDH1A1PKM
SCHEMBL1873977 0.68 ALDH1A1 (0.68) SMN1; SMN2ALDH1A1LMNAMAPTPKM
SCHEMBL112999 0.68 ALDH1A1 (0.68) SMN1; SMN2ALDH1A1LMNAMAPTPKM
SCHEMBL1332625 0.68 ALDH1A1 (0.68) SMN1; SMN2ALDH1A1LMNAMAPTPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080743-A AS CHEMICAL INTERMEIDATES FOR PREPARING DRUGS NOVARTIS AG (CH) 2000-06-27 US disclosed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP disclosed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO disclosed